{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:54:14Z","timestamp":1773957254101,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["NN401 647340"],"award-info":[{"award-number":["NN401 647340"]}]},{"name":"Institute of Pharmacology"},{"DOI":"10.13039\/501100004382","name":"Polish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.neuroscience.2016.02.072","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T17:19:39Z","timestamp":1457371179000},"page":"92-106","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats"],"prefix":"10.1016","volume":"324","author":[{"given":"J.","family":"Konieczny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2016.02.072_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0006-8993(74)90110-3","article-title":"Chemical or electrolytic lesion of the substantial nigra: early effects on neostriatal dopamine metabolism","volume":"74","author":"Agid","year":"1974","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0028-3908(84)90192-8","article-title":"Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats","volume":"23","author":"Altar","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00431958","article-title":"GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters","volume":"62","author":"Arnt","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnbeh.2015.00068","article-title":"Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated \u03b1-synuclein","volume":"9","author":"Bentea","year":"2015","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(92)90557-P","article-title":"Factors in amphetamine-induced contralateral rotation in the unilateral 6-OHDA lesion rat model during the first-week postoperative: implications for neuropathology and neural grafting","volume":"570","author":"Carey","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0300-9084(01)01250-0","article-title":"Degradation of oxidized proteins by the 20S proteasome","volume":"83","author":"Davies","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0035","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(95)00705-U","article-title":"Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats","volume":"695","author":"Espino","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0045","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","article-title":"Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition","volume":"23","author":"Fornai","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0050","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","article-title":"Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy","volume":"84","author":"Hirsch","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0055","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1995.64020794.x","article-title":"Neurotoxic effect of intranigral injection of 1-methyl-4-phenylpyridinium on GABA-containing neurons and its relation to circling behavior","volume":"64","author":"Jasso-L\u00f3pez","year":"1995","journal-title":"J Neurochem"},{"issue":"Suppl 3","key":"10.1016\/j.neuroscience.2016.02.072_b0060","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/neur.1995.0016","article-title":"6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death","volume":"4","author":"Jeon","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0070","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998","article-title":"Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter","volume":"18","author":"Jones","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0531-5131(03)01573-5","article-title":"Hemiparkinsonian rat models: different sensitivity of dopaminergic neurotoxins","volume":"1260","author":"Kondo","year":"2004","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2013.12.019","article-title":"Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra","volume":"261","author":"Konieczny","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12640-014-9477-9","article-title":"Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson\u2019s disease","volume":"26","author":"Konieczny","year":"2014","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbr.2015.01.043","article-title":"Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson\u2019s disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA","volume":"283","author":"Konieczny","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0100","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jnr.22611","article-title":"Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human \u03b1-synuclein","volume":"89","author":"Lam","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1471-4159.2001.00416.x","article-title":"Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production","volume":"78","author":"Lee","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0115","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD (1998)."},{"key":"10.1016\/j.neuroscience.2016.02.072_b0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0197-0186(00)00076-0","article-title":"The reverse transport of DA, what physiological significance?","volume":"38","author":"Leviel","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0125","series-title":"Handbuch der Neurologie","first-page":"920","article-title":"Paralysis agitans. I. Pathologische anatomic","author":"Lewy","year":"1912"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0304-3940(90)90463-J","article-title":"Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons","volume":"115","author":"Lindefors","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0135","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuint.2011.03.013","article-title":"Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson\u2019s disease in rats","volume":"58","author":"Lorenc-Koci","year":"2011","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0140","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0145","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1074\/jbc.M005385200","article-title":"The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity","volume":"275","author":"Lotharius","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0166-4328(89)80073-7","article-title":"Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical reorganization","volume":"32","author":"Lynch","year":"1989","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.expneurol.2013.03.021","article-title":"Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: Behavior, positron emission tomography, immunohistochemistry","volume":"247","author":"Mackey","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0160","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-3565(25)13418-6","article-title":"Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals","volume":"247","author":"Maura","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0170","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","article-title":"Proteasome inhibition causes nigral degeneration with inclusion bodies in rats","volume":"13","author":"McNaught","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(98)00189-4","article-title":"Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion","volume":"88","author":"Meshul","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbr.2009.01.017","article-title":"Amphetamine-evoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior","volume":"200","author":"Paquette","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0190","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2013.06.008","article-title":"A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats","volume":"248","author":"Pienaar","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00429-013-0669-5","article-title":"An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson\u2019s disease","volume":"220","author":"Pienaar","year":"2015","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0306-4522(80)90048-2","article-title":"Turning behaviour in animals","volume":"5","author":"Pycock","year":"1980","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0215","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/biom5020282","article-title":"Seeking a mechanism for the toxicity of oligomeric \u03b1-synuclein","volume":"5","author":"Roberts","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0220","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(88)91560-0","article-title":"Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats","volume":"450","author":"Robinson","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0225","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1523\/JNEUROSCI.14-05-02687.1994","article-title":"Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system","volume":"14","author":"Robinson","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/syn.890170103","article-title":"Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra","volume":"17","author":"Robinson","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(75)90304-4","article-title":"Mechanisms of action of 6-hydroxydopamine","volume":"24","author":"Sachs","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0240","first-page":"846725","article-title":"Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition","author":"Sala","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0255","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jnc.12686","article-title":"Protective and toxic roles of dopamine in Parkinson\u2019s disease","volume":"129","author":"Segura-Aguilar","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0260","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0265","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1096\/fj.03-1112rev","article-title":"Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?","volume":"18","author":"Sidhu","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.05.051","article-title":"Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion","volume":"1051","author":"Sindhu","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0275","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0280","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0285","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1111\/ejn.12660","article-title":"Selective increase of in vivo firing frequencies in DA SN neurons after proteasome inhibition in the ventral midbrain","volume":"40","author":"Subramaniam","year":"2014","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0290","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","article-title":"Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport","volume":"15","author":"Sulzer","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245141","article-title":"Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+","volume":"74","author":"Sun","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0300","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0014-5793(01)03115-5","article-title":"Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome","volume":"509","author":"Tofaris","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0149-7634(99)00063-9","article-title":"Structure and function of dopamine receptors","volume":"24","author":"Vallone","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-11-1","article-title":"Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson\u2019s disease","volume":"11","author":"Vernon","year":"2010","journal-title":"BMC Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2016.02.072_b0315","doi-asserted-by":"crossref","first-page":"e17269","DOI":"10.1371\/journal.pone.0017269","article-title":"Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson\u2019s disease","volume":"6","author":"Vernon","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0320","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0325","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/bi0102398","article-title":"Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson\u2019s disease","volume":"40","author":"Volles","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0330","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3892\/etm.2015.2432","article-title":"Effect of lysosomal and ubiquitin-proteasome system dysfunction on the abnormal aggregation of \u03b1-synuclein in PC12 cells","volume":"9","author":"Wang","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0335","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1124\/jpet.107.127597","article-title":"Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells","volume":"323","author":"Watabe","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0340","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1471-4159.2010.06914.x","article-title":"Proteasome inhibition modeling nigral neuron degeneration in Parkinson\u2019s disease","volume":"115","author":"Xie","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0345","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.20932","article-title":"Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats","volume":"60","author":"Zeng","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0350","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijdevneu.2014.04.003","article-title":"Dynamic of neurochemical alterations in striatum, hippocampus and cortex after the 6-OHDA mesostriatal lesion","volume":"36","author":"Zhang","year":"2014","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.072_b0355","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","article-title":"Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators","volume":"21","author":"Zhu","year":"2007","journal-title":"FASEB J"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216002220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216002220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T17:26:13Z","timestamp":1748798773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452216002220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":69,"alternative-id":["S0306452216002220"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2016.02.072","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}